Tuberous sclerosis

Handbook of Clinical Neurology

Volumn 111, Issue , 2013, Pages 323-331

  Curatolo, P ^a   Maria, B L ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876808744     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52891-9.00038-5     Document Type: Chapter

References (51)

1. Bombardieri R., Pinci M., Moavero R., et al. Early control of seizures improves long-term outcome in tuberous sclerosis complex. Eur J Paediatr Neurol 2010, 14:146-149.
2. Bruni O., Cortesi F., Giannotti F., et al. Sleep disorders in tuberous sclerosis: a polysomnographic study. Brain Dev 1995, 17:52-56.
3. Calcagnotto M.E., Paredes M.F., Tihan T., et al. Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 2005, 25:9649-9657.
4. Chiron C., Dulac O., Luna D., et al. Vigabatrin in infantile spasms. Lancet 1990, 335:363-367.
5. Chugani D.C., Chugani H.T., Muzik O., et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 1998, 44:858-866.
6. Crino P.B. Molecular pathogenesis of tuber formation in tuberous sclerosis complex. J Child Neurol 2004, 19:716-725.
7. Curatolo P. Tuberous Sclerosis Complex. From Basic Science to Clinical Phenotypes 2003, Edited by ICN Association, Mac Keith Press, London.
8. Curatolo P., Verdecchia M., Bombardieri R. Vigabatrin for tuberous sclerosis complex. Brain Dev 2001, 23:649-653.
9. Curatolo P., Porfirio M.C., Manzi B., et al. Autism in tuberous sclerosis. Eur J Paediatr Neurol 2004, 8:327-332.
10. Curatolo P., Bombardieri R., Jozwiak S. Tuberous sclerosis. Lancet 2008, 372:657-658.
11. Curatolo P., Lo-Castro A., Pinci M., et al. Neuroimaging findings of Sturge-Weber syndrome in a child with tuberous sclerosis. Brain Dev 2009, 31:352-355.
12. Cusmai R., Chiron C., Curatolo P., et al. Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia 1990, 31:747-755.
13. d'Agati E., Moavero R., Cerminara C., et al. Attention deficit hyperactivity disorder (ADHD) and tuberous sclerosis. J Child Neurol 2009, 24:1282-1287.
14. Dabora S.L., Jozwiak S., Franz D.N., et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001, 68:64-80.
15. De Vries P., Humphrey A., McCartney D., et al. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis. Eur Child Adolesc Psychiatry 2005, 14:183-190.
16. De Vries P.J., Hunt A., Bolton P.F. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry 2007, 16:16-24.
17. DiMario F.J. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 2004, 19:650-657.
18. Ehninger D., Han S., Shilyansky, et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 2008, 14:843-848.
19. Franz D.N., Leonard J., Tudor C., et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 2006, 59:490-498.
20. Garami A., Zwartkruis F.J., Nobukuni T., et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003, 11:1457-1466.
21. Goh S., Butler W., Thiele E.A. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 2004, 63:1457-1461.
22. Gomez M. Natural history of cerebral tuberous sclerosis. Tuberous Sclerosis Complex. Developmental Perspectives in Psychiatry 1999, Oxford University Press, New York, pp. 29-46.
23. Hancock E., Osborne J.P. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999, 14:71-74.
24. Humphrey A., Higgins J.N., Yates J.R., et al. Monozygotic twins with tuberous sclerosis discordant for the severity of developmental deficits. Neurology 2004, 62:795-798.
25. Jambaque I., Chiron C., Dumas C., et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000, 38:151-160.
26. Jansen F.E., Huiskamp G., van Huffelen A.C., et al. Identification of epileptogenic tubers in patients with tuberous sclerosis complex. Epilepsia 2006, 47:108-114.
27. Jansen A.C., Sancak O., D'Agostino M.D., et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Ann Neurol 2006, 60:528-539.
28. Jansen F.E., van Huffelen A.C., Algra A., et al. Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 2007, 48:1477-1484.
29. Jansen F.E., Braams O., Vincken K.L., et al. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 2008, 70:908-915.
30. Joinson C., O'Callaghan F.J., Osborne J.P., et al. Learning disability in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003, 33:335-344.
31. Jozwiak J. Hamartin and tuberin: working together for tumour suppression. Int J Cancer 2006, 118:1-5.
32. Khare L., Strizheva G.D., Bailey J.N., et al. A novel missense mutation in the GTPase activating protein homology region of TSC in two large families with tuberous sclerosis complex. J Med Genet 2001, 38:347-349.
33. Krueger D.A., Care M.M., Holland K., et al. Everolimus for subependymal giant cell astrocytomas in tuberous sclerosis. N Eng J Med 2010, 363:1801-1811.
34. Lortie A., Plouin P., Chiron C., et al. Characteristics of epilepsy in focal cortical dysplasia in infancy. Epilepsy Res 2002, 51:133-145.
35. Major P., Thiele E.A. Vagus nerve stimulation for intractable epilepsy in tuberous sclerosis complex. Epilepsy Behav 2008, 13:357-360.
36. Moavero R., Pinci M., Bombardieri R., et al. The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective. Childs Nerv Syst 2011, 27:1203-1210.
37. Nabbout R., Santos M., Rolland Y., et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999, 66:370-375.
38. Napolioni V., Moavero R., Curatolo P. Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev 2009, 31:104-113.
39. O'Callaghan F.J., Martyn C.N., Renowden S., et al. Subependymal nodules, giant cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child 2008, 93:751-754.
40. Park S.H., Pepkowitz S.H., Kerfoot C., et al. Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study. Acta Neuropathol 1997, 94:180-186.
41. Raznahan A., Higgins N.P., Griffiths P.D., et al. Biological markers of intellectual disability in tuberous sclerosis. Psychol Med 2007, 37:1293-1304.
42. Ridler K., Suckling J., Higgins N.J., et al. Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex 2007, 17:261-271.
43. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference: revised diagnostic criteria. J Child Neurol 1998, 13:624-628.
44. Sancak O., Nellist M., Goedbloed M., et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005, 13:731-741.
45. Seri S., Cerquiglini A., Pisani F., et al. Frontal lobe epilepsy associated with tuberous sclerosis: electroencephalographic-magnetic resonance imaging fusioning. J Child Neurol 1998, 13:33-38.
46. Shepherd C.W., Gomez M.R., Lie J.T., et al. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991, 66:792-796.
47. Van Slegtenhorst M., Nellist M., Nagelkerken B., et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 1998, 7:1053-1057.
48. Weiner H.L., Carlson C., Ridgway E.B., et al. Epilepsy surgery for children with tuberous sclerosis complex: results of a novel approach. J Child Neurol 2004, 19:687-689.
49. White R., Hua Y., Scheithauer B., et al. Selective alterations of glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 2001, 49:67-78.
50. Wu J.Y., Sutherling W.W., Koh S., et al. Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex. Neurology 2006, 66:1270-1272.
51. Zeng L.H., Xu L., Gutmann D.H., et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008, 63:444-453.